DOP073 Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe diseaseRaja Atreya, Markus F. Neurath, Christian Maaser et al.|Journal of Crohn s and Colitis|2017Cited by 2
New treatment targets in autoimmune hepatitis: detection using integrative omics and target validation in a proof of concept phase II clinical trialJan Philipp Weltzsch, Ansgar W. Lohse, Yang Xu et al.|Zeitschrift für Gastroenterologie|2025Cited by 0
THU-311-YI Uncovering novel therapeutic targets for autoimmune hepatitis (AIH): detection via omics integration and validation in proof-of- concept clinical trialYang Xu, Ansgar W. Lohse, Jan Philipp Weltzsch et al.|Journal of Hepatology|2025Cited by 0